MELPIDA
Live / Allowed — Notice of allowance issued (as of 25 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 04 Feb 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99633206
- Mark type
- Stylized text
- Filed
- 04 Feb 2026
- Published for opposition
- 30 Jun 2026
- Attorney of record
- Caroline E. Bryce
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for gene therapy for the treatment of progressive genetic neurological disorders, neurogenetic diseases, neurodegenerative diseases
Owner
- Elpida Therapeutics, Encino, CA, US
- Elpida Therapeutics, Encino, CA, US
Prosecution history
- 25 Aug 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 30 Jun 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Jun 2026 — PUBLISHED FOR OPPOSITION
- 24 Jun 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Jun 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Jun 2026 — ASSIGNED TO EXAMINER
- 04 Feb 2026 — APPLICATION FILING RECEIPT MAILED
- 04 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 04 Feb 2026 — NEW APPLICATION ENTERED